US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,227.22

-2.7581-0.22%

Number of Gainers:5

Number of Losers:2

Number of Flat:- -

PE:- -

High:1,235.50

Open:1,229.44

Low:1,215.23

Close:1,229.98

Loading ...

Exchange Traded Funds Top 10 Percentage Losers

Camurus Says Co And Lilly Enter Collaboration And License Agreement For Long-Acting Fluidcrystal® Incretins

Hims & Hers Seeks Growth in Europe as Weight-Loss Business Shifts -- Barrons.com

EXCLUSIVE-Wegovy use up 50% among US teens

How Moderna Went From Pandemic Hero to Vaccine Victim -- WSJ

Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Sagimet Biosciences, Inc. Class A (SGMT) and Janux Therapeutics Inc (JANX)

3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in June

Arvinas-Pfizer partnership dynamics may shift, says H.C. Wainwright

BRIEF-Lilly Presents First Clinical Data For Its Investigational, Next-Generation Frα

Imdelltra® Significantly Reduced Risk of Death by 40% in Small Cell Lung Cancer Patients

THOMSON REUTERS

Amgen Inc - Imdelltra Extends Median Overall Survival to 13.6 Months

THOMSON REUTERS

Amgen Inc - Imdelltra Shows Survival Advantage Over Standard Chemotherapy

THOMSON REUTERS

Eli Lilly and Co - Preliminary Orr of 55% at 4 Mg/Kg Dose

THOMSON REUTERS

Lilly Presents First Clinical Data for Its Investigational, Next-Generation FrΑ Targeting ADC in Platinum-Resistant Ovarian Cancer at the 2025 Asco Annual Meeting

THOMSON REUTERS

Amgen drug cuts small cell lung cancer death risk by 40%

Arvinas Shares Sink After Breast Cancer Treatment Didn't Improve Survival in Intent-to-Treat Population

GrÜNenthal: Financial Terms of Transaction Are Not Disclosed

THOMSON REUTERS

Could Viking Therapeutics Become the Next Eli Lilly?

Arvinas, Pfizer announce VERITAC-2 trial did not reach statistical significance

Terrible News for Pfizer Stock Investors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK4599/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1227.2213,"timestamp":1748980799999,"preClose":1229.9794,"halted":0,"volume":57910809,"delay":0,"changeRate":-0.002242,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":-2.758057,"latestTime":"06-03 16:00:00 EDT","open":1229.4404,"high":1235.5029,"low":1215.2319,"amount":4579904949.624046,"amplitude":0.016481,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749043800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":9.460628,"peRate":31.580481,"turnoverRate":0.005473,"increases":5,"decrements":2,"flats":0,"marketCap":1319463330624,"floatMarketCap":1228251433440},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1235.5029,"amplitude":0.016481,"preClose":1229.9794,"low":1215.2319,"pbRate":"9.460628","latestPrice":1227.2213,"volume":57910809,"delay":0,"open":1229.4404,"prevYearClose":1305.0607,"prevWeekClose":1216.6,"prevMonthClose":1216.6,"prevQuarterClose":1314.3724,"fiveDayClose":1197.4937,"twentyDayClose":1286.0837,"sixtyDayClose":1432.6436,"secType":"PLATE","market":"US","turnoverRate":0.005473,"peRate":31.580481,"marketCap":1319463330624,"floatMarketCap":1228251433440,"timestamp":1748980799999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":5,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2540670703","title":"Exchange Traded Funds Top 10 Percentage Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2540670703","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540670703?lang=en_us&edition=fundamental","pubTime":"2025-06-04 05:37","pubTimestamp":1748986620,"startTime":"0","endTime":"0","summary":"NET% STOCK LASTCHGCHG GrShr 2x Sh COIN DailyCONI5.49-0.60-9.85 Defiance Tgt 2X Shrt SMCI SMCZ7.28-0.78-9.68 Direxion Dly Semi 3 BearSOXS11.35-1.02-8.25 Defiance Dly Tgt 2x ShSMST27.03-2.33-7.94 ProSh UltSh Ether ETFETHD14.72-1.19-7.48 Defiance Tgt 2X Lg HIMSHIMZ37.84-2.91-7.14 Direxion Hi Beta Bear 3XHIBS11.96-0.75-5.90 ProSh UltSh SemiconSSG16.37-1.00-5.76 GrShr 2x Sh NVDA DailyNVD15.94-0.94-5.57 Defiance Target 2X Lg NVO NVOX6.91-0.37-5.08","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","SMCI","BK4532","BK4588","BK4543","BK4599","IE00BZ1G4Q59.USD","LU0154236417.USD","LU1093756325.SGD","LU1861220033.SGD","BK4170","LU0053671581.USD","LU1093756168.USD","BK4007","LU1861215975.USD","BK4585"],"gpt_icon":1},{"id":"2540709636","title":"Camurus Says Co And Lilly Enter Collaboration And License Agreement For Long-Acting Fluidcrystal® Incretins","url":"https://stock-news.laohu8.com/highlight/detail?id=2540709636","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540709636?lang=en_us&edition=fundamental","pubTime":"2025-06-04 01:58","pubTimestamp":1748973531,"startTime":"0","endTime":"0","summary":"June 3 (Reuters) - Camurus AB ::*CAMURUS AND LILLY ENTER COLLABORATION AND LICENSE AGREEMENT FOR LONG-ACTING FLUIDCRYSTAL INCRETINS*CAMURUS AB - ELIGIBLE FOR UP TO $870 MILLION IN MILESTONE PAYMENTS*C","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nRSD8xCrx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2456880835.USD","LU0234572021.USD","LU0786609619.USD","IE00BK4W5L77.USD","IE00B4R5TH58.HKD","LU1093756168.USD","LU2063271972.USD","LU0708995401.HKD","LU0882574139.USD","LU2471134879.HKD","BK4533","LU1267930730.SGD","LU0640476718.USD","LU1366192091.USD","SG9999015986.USD","LU2750360997.AUD","LU0889565916.HKD","SGXZ81514606.USD","LU1551013342.USD","LU2417539215.USD","IE00BJLML261.HKD","LU2357305700.SGD","LU2552382215.SGD","LU1551013425.SGD","LLY","IE00BK4W5M84.HKD","LU1069344957.HKD","LU2750360641.GBP","IE00BJJMRZ35.SGD","LU0320765059.SGD","LU1232071149.USD","LU0820561818.USD","LU1868836914.USD","LU0471298694.HKD","LU1548497426.USD","LU1720051108.HKD","LU0256863902.USD","LU2471134796.USD","LU2265009873.SGD","BK4599","LU0672654240.SGD","LU0466842654.USD","LU2211815571.USD","SG9999001176.USD","LU2237443978.SGD","IE00BFTCPJ56.SGD","LU0266013472.USD","LU2237443465.HKD","LU1868837136.USD","LU1093756325.SGD"],"gpt_icon":1},{"id":"2540708101","title":"Hims & Hers Seeks Growth in Europe as Weight-Loss Business Shifts -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2540708101","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540708101?lang=en_us&edition=fundamental","pubTime":"2025-06-03 23:03","pubTimestamp":1748962980,"startTime":"0","endTime":"0","summary":"As Hims & Hers Health adjusts to the end of the knockoff weight-loss-drug bonanza, the online drug retailer reached a deal to expand its reach into Europe.Hims said early Tuesday that it had agreed to buy a private European telehealth company called Zava, which operates in the U.K., Germany, France, and Ireland.Like Hims, Zava offers prescriptions and medicines online, and sells drugs such as generic treatments for erectile dysfunction and hair loss. Hims did not say how much it would pay for Zava.The deal comes at a challenging moment for Hims, which saw its market value climb to more than $15 billion at its peak in February from less than $2 billion in early 2024, amid excitement about its ability to sell cheap, legal copycat versions of Novo Nordisk's GLP-1 weight loss shot Wegovy.Hims shares were up 14.7% on Tuesday morning, and the stock is up more than 170% this year.Hims has ambitious plans to offer more-personalized treatments, incorporating compounding and lab tests. Adding an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","BK4599","BK4532","BK4588","BK4007","IE00BKVL7J92.USD","LU0154236417.USD","BK4196","LU1093756168.USD","BK4585","IE00BZ1G4Q59.USD","LU1093756325.SGD"],"gpt_icon":1},{"id":"2540772179","title":"EXCLUSIVE-Wegovy use up 50% among US teens","url":"https://stock-news.laohu8.com/highlight/detail?id=2540772179","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540772179?lang=en_us&edition=fundamental","pubTime":"2025-06-03 21:43","pubTimestamp":1748958224,"startTime":"0","endTime":"0","summary":"EXCLUSIVE-Wegovy use up 50% among US teensWegovy prescriptions for teens remain a small fraction of those with obesityInsurance hurdles limit use among doctors treating adolescentsExperts emphasize need for monitoring, lifestyle changes alongside GLP-1 medicationsAdds link to study in sixth paragraphBy Chad Terhune and Robin Respaut","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250603:nL6N3S60M9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1280957306.USD","LU0058720904.USD","LU2089984988.USD","LU1035775433.USD","LU0061475181.USD","GB00BDT5M118.USD","LU2602419157.SGD","LU1069344957.HKD","LU1057294990.SGD","LU2456880835.USD","LU0203202063.USD","LU1868836591.USD","LU2491050154.USD","SG9999015978.USD","LU0471298777.SGD","LU1623119135.USD","LU0882574055.USD","LU2237443382.USD","LU1983299246.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2265009873.SGD","LU2552382058.USD","LU0354030438.USD","LU1814569148.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","SGXZ99366536.SGD","LU2237443622.USD","BK4533","SG9999014880.SGD","LU0320765059.SGD","LU2324357040.USD","LU2237443549.SGD","LU1868837136.USD","IE00B1BXHZ80.USD","LU0289739699.SGD","IE0002141913.USD","LU0079474960.USD","LU2236285917.USD","BK4599","LU0094547139.USD","LU2106854487.HKD","SG9999001176.SGD","LU0456855351.SGD","LU2750360997.AUD","LU0823416689.USD","SG9999001176.USD","LU0385154629.USD"],"gpt_icon":1},{"id":"2540166779","title":"How Moderna Went From Pandemic Hero to Vaccine Victim -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2540166779","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540166779?lang=en_us&edition=fundamental","pubTime":"2025-06-03 19:59","pubTimestamp":1748951940,"startTime":"0","endTime":"0","summary":"Moderna was once a darling of the first Trump administration, which went to great lengths to help the company develop its Covid-19 vaccine that protected millions of people from the virus. Now the biotech is caught in the crossfire of Trump 2.0 as vaccine-making comes under fire.In the latest setback for Moderna, the Food and Drug Administration on Friday approved its next-generation Covid shot for a narrower population of patients than the company intended. The approval grants use of the vaccine only in older adults and people aged 12 to 64 with health risks.HHS Secretary Robert F. Kennedy Jr., a longtime vaccine skeptic, said recently that certain shots for respiratory diseases including mRNA vaccines have \"never worked.\" In mid-May, Kennedy said the Centers for Disease Control and Prevention would no longer recommend that pregnant women and children get Covid-19 vaccines as a matter of routine. The industry is also navigating an FDA that has shed thousands of workers.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0306807586.USD","BK4599","BK4532","BK4592","LU0225284248.USD","LU1829250122.USD","IE00BLSP4452.SGD","GSK","LU0234572021.USD","PFE","SG9999001176.USD","LU1883839398.USD","LU0058720904.USD","LU0289739699.SGD","SG9999011175.SGD","LU1066051498.USD","SG9999002224.SGD","BK4585","BK4139","LU0122379950.USD","IE000M9KFDE8.USD","BK4551","LU0306806265.USD","BK4581","LU0985481810.HKD","MRNA","LU0456855351.SGD","LU1057294990.SGD","SG9999002232.USD","SGXZ57979304.SGD","BK4534","BK4588","SG9999001176.SGD","LU0225771236.USD","IE0002270589.USD","LU0321505439.SGD","LU0170899867.USD","BK4568","IE00BLSP4239.USD","BK4550","SG9999003800.SGD","GSK.UK","IE00B19Z3B42.SGD","BK4007","BK4501","IE00BBT3K403.USD","LU1066053197.SGD","LU1894683348.USD","LU0868494617.USD","BK4548"],"gpt_icon":0},{"id":"2540255557","title":"Analysts Conflicted on These Healthcare Names: Pfizer (PFE), Sagimet Biosciences, Inc. Class A (SGMT) and Janux Therapeutics Inc (JANX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2540255557","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540255557?lang=en_us&edition=fundamental","pubTime":"2025-06-03 16:10","pubTimestamp":1748938230,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Pfizer (PFE – Research Report), Sagimet Bioscience...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-sagimet-biosciences-inc-class-a-sgmt-and-janux-therapeutics-inc-janx-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-pfizer-pfe-sagimet-biosciences-inc-class-a-sgmt-and-janux-therapeutics-inc-janx-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0225284248.USD","LU0868494617.USD","SG9999002224.SGD","SG9999013999.USD","LU0289739699.SGD","JANX","IE00BLSP4452.SGD","LU1894683348.USD","BK4539","BK4599","LU0170899867.USD","SGMT","LU0234572021.USD","SGXZ57979304.SGD","SG9999002232.USD","BK4592","IE00BBT3K403.USD","BK4550","IE00B19Z3B42.SGD","LU1894683264.USD","PFE","HCSG","BK4588","LU0225771236.USD","LU0321505439.SGD","IE000M9KFDE8.USD","SG9999001176.USD","IE0002270589.USD","LU1023059063.AUD","LU1057294990.SGD","BK4137","LU0306806265.USD","LU1066053197.SGD","LU0058720904.USD","LU0985481810.HKD","IE00BLSP4239.USD","LU0321505868.SGD","BK4533","IE00B19Z3581.USD","LU0122379950.USD","BK4007","BK4581","LU0456855351.SGD","LU1066051498.USD","SG9999011175.SGD","BK4139","BK4534","SG9999003800.SGD","BK4568","LU0306807586.USD"],"gpt_icon":0},{"id":"2540740346","title":"3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in June","url":"https://stock-news.laohu8.com/highlight/detail?id=2540740346","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540740346?lang=en_us&edition=fundamental","pubTime":"2025-06-03 15:06","pubTimestamp":1748934360,"startTime":"0","endTime":"0","summary":"Three supercharged dividend stocks have the tools and intangibles to fatten investors' pocketbooks in June, and well beyond.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/06/03/3-ultra-high-yield-dividend-stocks-no-brainer-buy/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["SG9999001176.SGD","LU1057294990.SGD","LU0306806265.USD","BK4533","IE00BLSP4452.SGD","LU0289739699.SGD","SGXZ57979304.SGD","IE00BBT3K403.USD","BK4581","LU0321505868.SGD","PFE","SG9999013999.USD","US3Y.BOND","US12M.BOND","US6M.BOND","LU1023059063.AUD","LU0122379950.USD","BK4568","LU1894683348.USD","LU0306807586.USD","BK4534","BK4592","SG9999003800.SGD","BDC","IE00B19Z3B42.SGD","LU1066053197.SGD","LU0170899867.USD","LU0321505439.SGD","US10Y.BOND","LU1894683264.USD","IE000M9KFDE8.USD","LU0225771236.USD","LU1883839398.USD","US30Y.BOND","SG9999001176.USD","IE00BLSP4239.USD","US7Y.BOND","BK4550","LU0058720904.USD","BK4599","IE0002270589.USD","LU0868494617.USD","BK4148","SG9999002224.SGD","US2Y.BOND","US5Y.BOND","LU0234572021.USD","BK4585","BK4007","SG9999002232.USD"],"gpt_icon":1},{"id":"2540794105","title":"Arvinas-Pfizer partnership dynamics may shift, says H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2540794105","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540794105?lang=en_us&edition=fundamental","pubTime":"2025-06-02 23:45","pubTimestamp":1748879112,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Andrew Fein notes that Arvinas (ARVN) shared the final data from the VERITAC-2 trial, which the firm sees positioning vepde...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arvinas-pfizer-partnership-dynamics-may-shift-says-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arvinas-pfizer-partnership-dynamics-may-shift-says-h-c-wainwright-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0122379950.USD","BK4533","LU1023059063.AUD","SG9999001176.SGD","SG9999011175.SGD","PFE","LU0058720904.USD","BK4581","IE000M9KFDE8.USD","LU0289739699.SGD","LU0225284248.USD","LU0456855351.SGD","IE00BBT3K403.USD","SGXZ57979304.SGD","BK4592","IE00B19Z3B42.SGD","LU1066051498.USD","LU1066053197.SGD","BK4599","BK4568","LU1894683348.USD","IE00BLSP4452.SGD","LU1883839398.USD","BK4550","SG9999002232.USD","SG9999013999.USD","IE0002270589.USD","BK4588","LU0170899867.USD","BK4007","SG9999003800.SGD","LU1057294990.SGD","ARVN","LU0985481810.HKD","IE00BLSP4239.USD","SG9999002224.SGD","LU0321505868.SGD","BK4585","LU1894683264.USD","SG9999001176.USD","BK4534","LU0225771236.USD","LU0306807586.USD","IE00B19Z3581.USD","LU0321505439.SGD","LU0234572021.USD","LU0306806265.USD","LU0868494617.USD"],"gpt_icon":0},{"id":"2540694798","title":"BRIEF-Lilly Presents First Clinical Data For Its Investigational, Next-Generation Frα","url":"https://stock-news.laohu8.com/highlight/detail?id=2540694798","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540694798?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:21","pubTimestamp":1748866908,"startTime":"0","endTime":"0","summary":"BRIEF-Lilly Presents First Clinical Data For Its Investigational, Next-Generation FrαJune 2 (Reuters) - Eli Lilly and Co LLY.N:LILLY PRESENTS FIRST CLINICAL DATA FOR ITS INVESTIGATIONAL, NEXT-GENERATI","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S305E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443622.USD","LU0109394709.USD","LU0943347566.SGD","BK4599","LU2264538146.SGD","LU0882574055.USD","BK4516","LU1023059063.AUD","LU2746668461.USD","IE00BJJMRZ35.SGD","LU2468319806.SGD","LU0289739699.SGD","LU1551013425.SGD","LU1093756325.SGD","BK4585","LU2324357040.USD","LU0122379950.USD","LU2552382215.SGD","LU0640476718.USD","IE0004445239.USD","SG9999014898.SGD","LU0354030511.USD","BK4581","LU2750360997.AUD","LU1720051017.SGD","LU1988902786.USD","SG9999015945.SGD","LU0456855351.SGD","LU2471134952.CNY","LU1623119135.USD","SG9999018857.SGD","LU1917777945.USD","LU1989771016.USD","LU1720051108.HKD","IE00B1BXHZ80.USD","LU0471298694.HKD","LU1974910355.USD","LU2361044865.SGD","LU1064131342.USD","LU2552382132.HKD","IE00BFTCPJ56.SGD","LLY","LU2112291526.USD","LU2471134523.USD","LU0820561909.HKD","SG9999013999.USD","LU0320765992.SGD","LU0354030438.USD","LU2491050154.USD","LU1280957306.USD"],"gpt_icon":1},{"id":"2540760209","title":"Imdelltra® Significantly Reduced Risk of Death by 40% in Small Cell Lung Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2540760209","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540760209?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:04","pubTimestamp":1748865886,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nTUA2JCMM7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0122379950.USD","BK4581","LU1571399168.USD","BK4585","LU0058720904.USD","IE00B2B36J28.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1983299246.USD","BK4588","LU2089984988.USD","BK4566","BK4139","LU2468319806.SGD","LU0109394709.USD","LU2242646821.SGD","BK4533","LU2112291526.USD","AMGN","BK4534","LU1061106388.HKD","LU0889565916.HKD","LU0868494617.USD","LU1057294990.SGD","IE0009355771.USD","LU2242652126.USD","BK4599","SG9999001440.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2540760042","title":"Amgen Inc - Imdelltra Extends Median Overall Survival to 13.6 Months","url":"https://stock-news.laohu8.com/highlight/detail?id=2540760042","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540760042?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:04","pubTimestamp":1748865886,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nTUA2JCMM7:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","AMGN","LU1057294990.SGD","IE00B4R5TH58.HKD","LU0122379950.USD","LU0109394709.USD","BK4599","LU2089984988.USD","LU2112291526.USD","LU2242652126.USD","LU1983299246.USD","BK4588","LU0320765992.SGD","BK4534","IE00BFTCPJ56.SGD","LU2242646821.SGD","IE0009355771.USD","LU1061106388.HKD","LU1571399168.USD","BK4533","LU1023059063.AUD","BK4566","LU0868494617.USD","LU2468319806.SGD","BK4585","BK4139","BK4581","IE0002141913.USD","LU0058720904.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0289739699.SGD","IE00BJT1NW94.SGD","SG9999001440.SGD"],"gpt_icon":0},{"id":"2540023760","title":"Amgen Inc - Imdelltra Shows Survival Advantage Over Standard Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2540023760","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540023760?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:04","pubTimestamp":1748865886,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nTUA2JCMM7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B4R5TH58.HKD","BK4139","BK4599","BK4534","LU0320765992.SGD","LU2112291526.USD","LU0289739699.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4566","LU0889565916.HKD","IE00B2B36J28.USD","BK4533","LU1061106388.HKD","LU0109394709.USD","LU2242652126.USD","LU0058720904.USD","LU1983299246.USD","LU2242646821.SGD","IE0009355771.USD","LU1571399168.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU1023059063.AUD","BK4588","BK4585","BK4581","LU2089984988.USD","LU2468319806.SGD","LU0868494617.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","LU0122379950.USD","AMGN"],"gpt_icon":0},{"id":"2540760288","title":"Eli Lilly and Co - Preliminary Orr of 55% at 4 Mg/Kg Dose","url":"https://stock-news.laohu8.com/highlight/detail?id=2540760288","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540760288?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:00","pubTimestamp":1748865619,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S305E:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1974910355.USD","LU2471134952.CNY","GB00BDT5M118.USD","LU2106854487.HKD","SG9999014914.USD","LU1291159041.SGD","LU2360106947.USD","LU0114720955.EUR","LU0094547139.USD","LU1720051108.HKD","SGXZ31699556.SGD","LU0471298777.SGD","LU2237443382.USD","LU0079474960.USD","LU0198837287.USD","LU0823416689.USD","LU1127390331.HKD","IE00BJT1NW94.SGD","LU2491050154.USD","LU0323591593.USD","BK4599","LU2237443622.USD","SG9999013999.USD","LU0256863902.USD","LU1366192091.USD","SG9999014880.SGD","LU2264538146.SGD","LU2552382058.USD","LU0109394709.USD","LU0203201768.USD","SGXZ99366536.SGD","LU1023059063.AUD","LU0943347566.SGD","LLY","LU1280957306.USD","LU2265009873.SGD","BK4588","SGXZ51526630.SGD","LU1267930730.SGD","BK4534","LU2023250504.SGD","LU2361044865.SGD","LU0672654240.SGD","LU1868836591.USD","LU2471134796.USD","SG9999015978.USD","BK4581","LU0289739699.SGD","LU1548497426.USD","LU0097036916.USD"],"gpt_icon":0},{"id":"2540407760","title":"Lilly Presents First Clinical Data for Its Investigational, Next-Generation FrΑ Targeting ADC in Platinum-Resistant Ovarian Cancer at the 2025 Asco Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2540407760","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540407760?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:00","pubTimestamp":1748865619,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S305E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1974910355.USD","LU2471134952.CNY","GB00BDT5M118.USD","LU2106854487.HKD","SG9999014914.USD","LU1291159041.SGD","LU2360106947.USD","LU0114720955.EUR","LU0094547139.USD","LU1720051108.HKD","SGXZ31699556.SGD","LU0471298777.SGD","LU2237443382.USD","LU0079474960.USD","LU0198837287.USD","LU0823416689.USD","LU1127390331.HKD","IE00BJT1NW94.SGD","LU2491050154.USD","LU0323591593.USD","BK4599","LU2237443622.USD","SG9999013999.USD","LU0256863902.USD","LU1366192091.USD","SG9999014880.SGD","LU2264538146.SGD","LU2552382058.USD","LU0109394709.USD","LU0203201768.USD","SGXZ99366536.SGD","LU1023059063.AUD","LU0943347566.SGD","LLY","LU1280957306.USD","LU2265009873.SGD","BK4588","SGXZ51526630.SGD","LU1267930730.SGD","BK4534","LU2023250504.SGD","LU2361044865.SGD","LU0672654240.SGD","LU1868836591.USD","LU2471134796.USD","SG9999015978.USD","BK4581","LU0289739699.SGD","LU1548497426.USD","LU0097036916.USD"],"gpt_icon":0},{"id":"2540602327","title":"Amgen drug cuts small cell lung cancer death risk by 40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540602327","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540602327?lang=en_us&edition=fundamental","pubTime":"2025-06-02 20:00","pubTimestamp":1748865600,"startTime":"0","endTime":"0","summary":"Amgen drug cuts small cell lung cancer death risk by 40% Imdelltra extended median survival by over 5 months27% of Imdelltra patients had serious side effects vs 62% of chemotherapy patientsTrial resu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nL2N3S10O8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1023059063.AUD","LU0320765992.SGD","LU0889565916.HKD","LU2468319806.SGD","AMGN","IE00BFTCPJ56.SGD","LU2089984988.USD","BK4533","IE00BJT1NW94.SGD","BK4566","BK4585","LU1061106388.HKD","IE00B2B36J28.USD","LU0289739699.SGD","LU0868494617.USD","IE00B4R5TH58.HKD","LU0109394709.USD","BK4534","BK4599","LU1571399168.USD","LU1983299246.USD","SG9999001440.SGD","BK4581","IE0002141913.USD","LU2242652126.USD","LU0122379950.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","LU2242646821.SGD","LU2112291526.USD","BK4588","BK4139","LU1057294990.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"2540767942","title":"Arvinas Shares Sink After Breast Cancer Treatment Didn't Improve Survival in Intent-to-Treat Population","url":"https://stock-news.laohu8.com/highlight/detail?id=2540767942","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540767942?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:16","pubTimestamp":1748862960,"startTime":"0","endTime":"0","summary":"Shares of Arvinas fell after the company said its in-development treatment for breast cancer didn't reach statistical significance in improving progression-free survival for its intent-to-treat population.The stock declined 9.7%, to $6.50, in pre-market trading Monday. Shares ended Friday's regular session 4% lower, at $7.20, having lost about three-quarters of their value in the past year.The biotechnology said that the therapy, vepdegestrant, notched a progression-free survival rate of 3.7 months in a recent Phase 3 study, compared with a progression-free survival rate of 3.6 months for fulvestrant, an existing breast cancer treatment.Arvinas noted that vepdegestrant, which is being developed alongside Pfizer to treat certain types of advanced or metastatic breast cancer, was generally well tolerated in the clinical trial, and that the therapy did demonstrate a meaningful improvement in progression-free survival among estrogen receptor 1 mutation patients.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","ARVN","LU0985481810.HKD","LU1883839398.USD","IE0002270589.USD","SG9999002232.USD","SG9999002224.SGD","BK4007","BK4534","BK4581","IE00BBT3K403.USD","LU1023059063.AUD","LU1057294990.SGD","LU1894683264.USD","BK4599","SG9999001176.SGD","SG9999013999.USD","SGXZ57979304.SGD","BK4550","BK4592","LU0306806265.USD","LU1066053197.SGD","LU0225771236.USD","IE000M9KFDE8.USD","BK4585","IE00B19Z3581.USD","LU0321505439.SGD","SG9999011175.SGD","BK4588","LU0289739699.SGD","SG9999001176.USD","LU1066051498.USD","LU0868494617.USD","LU0456855351.SGD","LU0321505868.SGD","LU1894683348.USD","LU0170899867.USD","LU0306807586.USD","BK4533","IE00BLSP4239.USD","LU0122379950.USD","LU0234572021.USD","LU0058720904.USD","LU0225284248.USD","SG9999003800.SGD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD"],"gpt_icon":1},{"id":"2540767827","title":"GrÜNenthal: Financial Terms of Transaction Are Not Disclosed","url":"https://stock-news.laohu8.com/highlight/detail?id=2540767827","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540767827?lang=en_us&edition=fundamental","pubTime":"2025-06-02 19:07","pubTimestamp":1748862451,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250602:nFWN3S30DF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1035775433.USD","LU1720051108.HKD","LU1267930730.SGD","LU1548497426.USD","LU1868837136.USD","LU2361044949.HKD","IE00B1BXHZ80.USD","LU0466842654.USD","LU0114720955.EUR","LU0708995401.HKD","LU2237443895.HKD","LU0289739699.SGD","LU0109394709.USD","BK4599","LU1983299246.USD","LU0471298777.SGD","LU2237443622.USD","LU2360106947.USD","BK4007","IE00BFTCPJ56.SGD","LU0689472784.USD","IE0009355771.USD","LU1127390331.HKD","LU1069344957.HKD","LU0266013472.USD","LU0256863902.USD","SGXZ81514606.USD","LU1551013425.SGD","SGXZ57979304.SGD","LU2471134796.USD","LU0238689110.USD","LU1720051017.SGD","SG9999015986.USD","LU2471134952.CNY","LU2237443382.USD","LU2023250504.SGD","LU2750360641.GBP","LU0097036916.USD","LU0079474960.USD","LU0256863811.USD","IE0004445239.USD","LU0882574139.USD","LU1974910355.USD","LU2237443978.SGD","LU1366192091.USD","LLY","LU0096364046.USD","LU0109391861.USD","LU0354030438.USD","LU2552382215.SGD"],"gpt_icon":0},{"id":"2540762190","title":"Could Viking Therapeutics Become the Next Eli Lilly?","url":"https://stock-news.laohu8.com/highlight/detail?id=2540762190","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540762190?lang=en_us&edition=fundamental","pubTime":"2025-06-02 18:45","pubTimestamp":1748861100,"startTime":"0","endTime":"0","summary":"Eli Lilly is a global healthcare giant, generating strong growth from a diverse portfolio of blockbuster medications.Viking Therapeutics has a weight-loss drug candidate VK2735, that aims to compete with Eli Lilly's Zepbound.The obesity treatment market is booming, with groundbreaking drugs like Eli Lilly's  Zepbound delivering transformative patient results and powering its stock to a spectacular 400% return in the past five years.Amid this estimated $100 billion opportunity, much smaller upstart Viking Therapeutics  has emerged with a promising clinical pipeline, aiming to capture a share of the weight loss and metabolic disease market with its novel dual-agonist approach. Despite a long road ahead for this clinical-stage biotech, recent data suggesting that its VK2735 candidate could rival and even outperform the leading therapies highlights the significant potential of this exciting small-cap stock.Could Viking Therapeutics be the next Eli Lilly?","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/06/02/could-viking-therapeutics-become-next-eli-lilly/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1868836757.USD","LU2361045086.USD","LU0354030438.USD","LU0203202063.USD","LU0061475181.USD","LU1868836591.USD","LU0640476718.USD","LU1093756168.USD","LU2602419157.SGD","SGXZ31699556.SGD","LU1267930730.SGD","LU0471298777.SGD","LU2360106947.USD","SG9999018865.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","LU0320765992.SGD","LU1623119135.USD","IE00BK4W5M84.HKD","LU2023250504.SGD","SG9999014914.USD","BK4599","LU2468319806.SGD","LU0106261372.USD","LU2471134879.HKD","LU2237443978.SGD","LU2264538146.SGD","VKTX","IE00B1BXHZ80.USD","LU1712237335.SGD","SG9999015978.USD","LU1983299246.USD","IE00B2B36J28.USD","LU2089984988.USD","LU2237443895.HKD","LU0097036916.USD","SGXZ99366536.SGD","LU0114720955.EUR","LU2491050154.USD","SG9999001176.USD","BK4534","LU0079474960.USD","LU2746668461.USD","LU0256863902.USD","LU1035775433.USD","LLY","LU1868837136.USD","LU0471298694.HKD","LU1127390331.HKD"],"gpt_icon":1},{"id":"2540309837","title":"Arvinas, Pfizer announce VERITAC-2 trial did not reach statistical significance","url":"https://stock-news.laohu8.com/highlight/detail?id=2540309837","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540309837?lang=en_us&edition=fundamental","pubTime":"2025-06-02 04:35","pubTimestamp":1748810121,"startTime":"0","endTime":"0","summary":"Arvinas (ARVN) and Pfizer (PFE) announced detailed results from the Phase 3 VERITAC-2 clinical trial evaluating vepdegestrant monotherapy versus fu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/arvinas-pfizer-announce-veritac-2-trial-did-not-reach-statistical-significance-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/arvinas-pfizer-announce-veritac-2-trial-did-not-reach-statistical-significance-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4592","LU0225771236.USD","SGXZ57979304.SGD","SG9999001176.USD","LU1894683348.USD","SG9999003800.SGD","SG9999011175.SGD","LU0289739699.SGD","LU0868494617.USD","BK4588","LU0306807586.USD","LU0306806265.USD","SG9999002224.SGD","IE000M9KFDE8.USD","LU0321505439.SGD","IE00BBT3K403.USD","IE00B19Z3B42.SGD","BK4007","LU0985481810.HKD","LU0321505868.SGD","SG9999013999.USD","LU1883839398.USD","IE0002270589.USD","LU0234572021.USD","LU1023059063.AUD","PFE","LU0456855351.SGD","BK4581","BK4585","SG9999002232.USD","IE00BLSP4452.SGD","BK4534","BK4599","SG9999001176.SGD","BK4533","LU0058720904.USD","IE00B19Z3581.USD","LU1057294990.SGD","LU1894683264.USD","BK4568","LU1066051498.USD","BK4550","IE00BLSP4239.USD","LU1066053197.SGD","LU0122379950.USD","LU0225284248.USD","ARVN","LU0170899867.USD"],"gpt_icon":0},{"id":"2540473493","title":"Terrible News for Pfizer Stock Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2540473493","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2540473493?lang=en_us&edition=fundamental","pubTime":"2025-06-01 21:15","pubTimestamp":1748783700,"startTime":"0","endTime":"0","summary":"While it no longer generates the sales it once did, Pfizer's coronavirus lineup remains critical to its results.However, recent regulatory changes in the U.S. should make this franchise somewhat less lucrative.Even so, Pfizer's hopes of a comeback lie elsewhere, especially in its improving oncology unit.Looking at the bigger picturePfizer's coronavirus franchise might weaken somewhat as a result of these changes, but perhaps not significantly. The FDA's guidance is largely irrelevant to Paxlovid. We could even speculate that lower vaccination rates may actually lead to higher infection rates and more prescriptions for the medicine. Although Comirnaty's U.S. sales will be affected, the company reported just $2.004 billion in revenue from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/06/01/terrible-news-for-pfizer-stock-investors/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["BK4550","LU0321505868.SGD","LU0321505439.SGD","LU0306806265.USD","LU0122379950.USD","LU0868494617.USD","SGXZ57979304.SGD","IE00B19Z3581.USD","BK4588","LU1066053197.SGD","LU1066051498.USD","SG9999002232.USD","LU0306807586.USD","BK4534","BK4581","IE00BBT3K403.USD","LU0170899867.USD","ISBC","BK4211","LU1023059063.AUD","BK4568","BK4585","IE000M9KFDE8.USD","SG9999011175.SGD","IE00BLSP4452.SGD","LU1894683348.USD","LU0234572021.USD","SG9999003800.SGD","SG9999002224.SGD","SG9999013999.USD","SG9999001176.USD","BK4533","LU0058720904.USD","IE00B19Z3B42.SGD","LU0289739699.SGD","LU1894683264.USD","IE00BLSP4239.USD","LU0225284248.USD","LU0225771236.USD","LU0456855351.SGD","LU1057294990.SGD","BK4599","LU1883839398.USD","BK4007","SG9999001176.SGD","BK4592","LU0985481810.HKD","PFE","IE0002270589.USD"],"gpt_icon":1}],"pageSize":20,"totalPage":6,"pageCount":1,"totalSize":119,"code":"91000000","status":"200"}]}}